The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 4, 2015, Pages 601-614

  Hu, Fulan ^a   Wu, Zhiwei ^a   Li, Guangxiao ^a   Teng, Chong ^b   Liu, Yupeng ^a   Wang, Fan ^a   Zhao, Yashuang ^a   Pang, Da ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Retinol; Vitamin A; Vitamin C; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; RETINOL;

ARTICLE; BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; META ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PUBLISHING; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; BLOOD; BREAST TUMOR; REGRESSION ANALYSIS; RISK; RISK FACTOR;

ALPHA-TOCOPHEROL; ASCORBIC ACID; BREAST NEOPLASMS; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS; VITAMIN A;

EID: 84925467305     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1852-7     Document Type: Article

References (63)

1. Abiaka C, Al-Awadi F, Gulshan S, Al-Sayer H, Behbehani A, Farghaly M, Simbeye A (2001) Plasma concentrations of alpha-tocopherol and urate in patients with different types of cancer. J Clin Pharm Ther 26:265–270
2. Aggarwal BB, Sundaram C, Prasad S, Kannappan R (2010) Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 80:1613–1631. doi:10.1016/j.bcp.2010.07.043
3. Aghvami T, Djalali M, Keshavarz A, Sadeghi MR, Zeraati H, Sadrzadeh Yeganeh H, Negahdar M (2006) Plasma level of antioxidant vitamins and lipid peroxidation in breast cancer patients. Iran J Public Health 35:42–47
4. Al-Saleh I, Al-Doush I (2002) Serum selenium and dl-(alpha)-tocopherol levels in women with breast cancer. Trace Elem Electrolytes 19:118–124
5. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181–193. doi:10.1038/35106036
6. Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617–631
7. Ascherio A, Stampfer MJ, Colditz GA, Rimm EB, Litin L, Willett WC (1992) Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J Nutr 122:1792–1801
8. Badid N et al (2010) Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 16:159–167. doi:10.1007/s12253-009-9199-0
9. Basu TK, Hill GB, Ng D, Abdi E, Temple N (1989) Serum vitamins A and E, beta-carotene, and selenium in patients with breast cancer. J Am Coll Nutr 8:524–529
10. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
11. Berlin JA, Longnecker MP, Greenland S (1993) Meta-analysis of epidemiologic dose–response data. Epidemiology 4:218–228
12. Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479–1483
13. Chene G, Thompson SG (1996) Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 144:610–621
14. Ching S, Ingram D, Hahnel R, Beilby J, Rossi E (2002) Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J Nutr 132:303–306
15. Chitkara N, Dadoo RC, Bansal S, Chugh K, Aggarwal SK, Lal H (1996) Plasma vitamin E levels in carcinoma breast. Indian J Clin Biochem 11:162–164
16. de Cavanagh EM, Honegger AE, Hofer E, Bordenave RH, Bullorsky EO, Chasseing NA, Fraga C (2002) Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients. Cancer 94:3247–3251. doi:10.1002/cncr.10611
17. Deharveng G, Charrondiere UR, Slimani N, Southgate DA, Riboli E (1999) Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 53:60–79
18. Dehghan M, Akhtar-Danesh N, McMillan CR, Thabane L (2007) Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr J 6:41. doi:10.1186/1475-2891-6-41
19. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HE Jr (1998) Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 9:89–97
20. Dorjgochoo T et al (2009) Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS). Breast Cancer Res Treat 117:381–389. doi:10.1007/s10549-008-0270-4
21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
22. Epplein M et al (2009) Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case–control study. Breast Cancer Res 11:R49. doi:10.1186/bcr2338
23. Fleiss JL (1993) The statistical basis of meta-analysis. Stat Methods Med Res 2:121–145
24. Foster RL (2012) Reporting guidelines: CONSORT, PRISMA, and SQUIRE. J Spec Pediatr Nurs 17:1–2. doi:10.1111/j.1744-6155.2011.00319.x
25. Freedman LS, Schatzkin A, Midthune D, Kipnis V (2011) Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst 103:1086–1092. doi:10.1093/jnci/djr189
26. Fulan H et al (2011) Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes Control 22:1383–1396. doi:10.1007/s10552-011-9811-y
27. Gerber M et al (1988) Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern France. Int J Cancer 42:489–494
28. Gerber M, Richardson S, de Paulet PC, Pujol H, de Paulet AC (1989) Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer 64:2347–2353
29. Gerber M, Richardson S, Salkeld R, Chappuis P (1991) Antioxidants in female breast cancer patients. Cancer Invest 9:421–428
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. doi:10.1136/bmj.327.7414.557
31. Hou MF et al (1998) Serum vitamin A level in breast cancer patients Kaohsiung. J Med Sci 14:673–678
32. Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E (2001) Carotenoids, alpha-tocopherols, and retinol in plasma and breast cancer risk in northern Sweden. Cancer Causes Control 12:529–537
33. Ito Y, Gajalakshmi KC, Sasaki R, Suzuki K, Shanta V (1999) A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. J Epidemiol 9:306–314
34. Kabat GC et al (2009) Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr 90:162–169. doi:10.3945/ajcn.2009.27568
35. Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7–16
36. Kim MK, Ahn SH, Lee-Kim YC (2001) Relationship of serum (alpha)-tocopherol, carotenoids and retinol with the risk of breast cancer. Nutr Res 21:797–809
37. Kim MK, Park YG, Gong G, Ahn SH (2002) Breast cancer, serum antioxidant vitamins, and p53 protein overexpression. Nutr Cancer 43:159–166. doi:10.1207/s15327914nc432_6
38. Kim M-K, Ahn SH, Son BH, Sung M-K (2010) Plasma antioxidant concentration, not superoxide dismutase polymorphism, is associated with breast cancer risk in Korean women. Nutr Res 30:705–713. doi:10.1016/j.nutres.2010.09.012
39. Knekt P (1988) Serum vitamin E level and risk of female cancers. Int J Epidemiol 17:281–286
40. Knekt P et al (1990) Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol 132:857–870
41. London SJ et al (1992) Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 3:503–512
42. Maillard V et al (2009) Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study. Int J Cancer 127:1188–1196. doi:10.1002/ijc.25138
43. Marubini E et al (1988) The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer. Results of a case–control study. Cancer 61:173–180
44. McPherson RAPM (2011) Henry’s clinical diagnosis and management by laboratory methods, 22nd edn. Elsevier Saunders, Philadelphia
45. Potischman N et al (1990) Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr 52:909–915
46. Ramaswamy G, Krishnamoorthy L (1996) Serum carotene, vitamin A, and vitamin C levels in breast cancer and cancer of the uterine cervix. Nutr Cancer 25:173–177. doi:10.1080/01635589609514439
47. Ray G, Husain SA (2001) Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34:71–76
48. Russell MJ, Thomas BS, Bulbrook RD (1988) A prospective study of the relationship between serum vitamins A and E and risk of breast cancer. Br J Cancer 57:213–215
49. Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, Comstock GW (2002) Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 11:451–457
50. Schrijver J, Alexieva-Figusch J, Van Breederode N, Van Gilse HA (1987) Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen. Nutr Cancer 10:231–245
51. Shah FD, Patel JB, Shukla SN, Shah PM, Patel PS (2009) Evaluation of plasma non-enzymatic antioxidants in breast cancer etiology. Asian Pac J Cancer Prev 10:91–96
52. Sharhar S et al (2008) Antioxidant intake and status, and oxidative stress in relation to breast cancer risk: a case–control study. Asian Pac J Cancer Prev 9:343–349
53. Simon MS, Djuric Z, Dunn B, Stephens D, Lababidi S, Heilbrun LK (2000) An evaluation of plasma antioxidant levels and the risk of breast cancer: a pilot case control study. Breast J 6:388–395
54. Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
55. Tamimi RM (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161:153–160. doi:10.1093/aje/kwi030
56. Thomas DB, Karagas MR (1987) Cancer in first and second generation Americans. Cancer Res 47:5771–5776
57. Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E (2001) Serum carotenoids and breast cancer. Am J Epidemiol 153:1142–1147
58. Torun M, Akgul S, Sargin H (1995a) Serum vitamin E level in patients with breast cancer. J Clin Pharm Ther 20:173–178
59. Torun M, Yardim S, Gonenc A, Sargin H, Menevse A, Simsek B (1995b) Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J Clin Pharm Ther 20:259–263
60. Trock BJ, Hilakivi-Clarke L, Clarke R (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459–471
61. Ullah MF, Khan HY, Zubair H, Shamim U, Hadi SM (2011) The antioxidant ascorbic acid mobilizes nuclear copper leading to a prooxidant breakage of cellular DNA: implications for chemotherapeutic action against cancer. Cancer Chemother Pharmacol 67:103–110. doi:10.1007/s00280-010-1290-4
62. WHO (2011(WHO/NMH/NHD/MNM/11.3)) Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations Vitamin and Mineral Nutrition Information System. World Health Organization, Geneva
63. Zaroukian S, Pineault R, Gandini S, Lacroix A, Ghadirian P (2005) Correlation between nutritional biomarkers and breast cancer: a case–control study. The Breast 14:209–223. doi:10.1016/j.breast.2005.01.001